Clinical Trial Update: Tofacitinib in Patients With Amyotrophic Lateral Sclerosis [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial is investigating tofacitinib in patients with amyotrophic lateral sclerosis, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Amyotrophic Lateral Sclerosis | EARLY_Phase 1 | Status: NOT_YET_RECRUITING